Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Implementation of Inflation-Indexed Rebates for Part B Drugs

The Inflation Reduction Act of 2022 requires CMS to collect rebates from drug manufacturers for certain Part B drugs if prices increase faster than inflation. The implementation date of these rebate provisions is the first quarter of 2023, meaning CMS must act quickly to comply with the legislative requirements. During the past decade, OIG completed three studies that estimated how much Medicare could have saved if manufacturers had paid rebates for Part B drugs. We also summarized several implementation issues that would need to be addressed to establish rebates for Part B drugs. This product will summarize insights from OIG's previous work with the goal of assisting CMS in its implementation efforts.

Announced or Revised Agency Title Component Report Number(s) Expected Issue Date (FY)
Completed Centers for Medicare and Medicaid Services Implementation of Inflation-Indexed Rebates for Part B Drugs Office of Evaluation and Inspections OEI-BL-23-00170 2023